OTCMTCNNF
Market cap915mUSD
Dec 23, Last price
4.84USD
1D
0.41%
1Q
-59.60%
IPO
-68.92%
Name
Trulieve Cannabis Corp
Chart & Performance
P/E
—
P/S
0.81
EPS
—
Div Yield, %
0.01%
Shrs. gr., 5y
12.86%
Rev. gr., 5y
61.49%
Revenues
1.13b
-8.92%
Net income
-527m
L+156.85%
CFO
202m
+773.92%
Earnings
Feb 26, 2025
Profile
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edible, vaporizer cartridge, concentrate, topical, capsule, tincture, dissolvable powder, and nasal spray products under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands. As of March 16, 2022, it operated 162 dispensaries, which included 113 dispensaries in Florida, 19 affiliated dispensaries in Pennsylvania, 17 dispensaries in Arizona, five dispensaries in California, three dispensaries in Maryland, two dispensaries in Massachusetts, two dispensaries in West Virginia, and one dispensary in Connecticut. Trulieve Cannabis Corp. also operated cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. The company was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Quincy, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 1,129,193 -8.92% | 1,239,800 32.12% | 938,385 79.93% | |||||
Cost of revenue | 926,727 | 1,012,400 | 687,972 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 202,466 | 227,400 | 250,413 | |||||
NOPBT Margin | 17.93% | 18.34% | 26.69% | |||||
Operating Taxes | 151,358 | 161,800 | 146,061 | |||||
Tax Rate | 74.76% | 71.15% | 58.33% | |||||
NOPAT | 51,108 | 65,600 | 104,352 | |||||
Net income | (526,796) 156.85% | (205,100) -1,237.42% | 18,032 -71.38% | |||||
Dividends | (50) | (48) | ||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | (466) | 18,011 | 216,824 | |||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 22,930 | 32,800 | 27,068 | |||||
Long-term debt | 1,079,381 | 1,377,400 | 1,211,545 | |||||
Deferred revenue | 2,895 | |||||||
Other long-term liabilities | 228,989 | 41,000 | 8,400 | |||||
Net debt | 900,939 | 1,185,913 | 995,836 | |||||
| Cash flow | ||||||||
Cash from operating activities | 201,841 | 23,096 | 12,898 | |||||
CAPEX | (40,385) | (184,583) | (306,115) | |||||
Cash from investing activities | (37,470) | (215,057) | (215,184) | |||||
Cash from financing activities | (175,585) | 177,796 | 289,232 | |||||
FCF | 198,391 | (28,242) | (524,751) | |||||
| Balance | ||||||||
Cash | 201,372 | 212,300 | 230,646 | |||||
Long term investments | 11,987 | 12,131 | ||||||
Excess cash | 144,912 | 162,297 | 195,857 | |||||
Stockholders' equity | (646,499) | (117,300) | 139,273 | |||||
Invested Capital | 3,076,671 | 3,066,300 | 2,845,458 | |||||
ROIC | 1.66% | 2.22% | 6.02% | |||||
ROCE | 7.68% | 7.17% | 7.74% | |||||
| EV | ||||||||
Common stock shares outstanding | 188,974 | 187,995 | 146,757 | |||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | 383,456 | 412,969 | 328,633 | |||||
EV/EBITDA | ||||||||
Interest | 81,569 | 79,800 | 34,787 | |||||
Interest/NOPBT | 40.29% | 35.09% | 13.89% | |||||